Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Radiologe ; 57(11): 973-986, 2017 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-29075871

RESUMO

Benign, intermediate and malignant soft tissue tumors can be differentiated histologically. Furthermore, the tumors can be subdivided according to their linear differentiation. In the new World Health Organization (WHO) classification of soft tissue tumors from 2013 changes have been made relating to the allocation of known entities, e. g. undifferentiated sarcomas have been formed into a new subgroup and are no longer assigned to the fibrohistiocytic tumors. The term malignant fibrous histiocytoma has been replaced by the undifferentiated sarcoma. Furthermore, two new subgroups were incorporated, the nerve sheath tumors and gastrointestinal stromal tumors. These were previously included in the tumor classification of other organ systems. These changes in the new classification are related to the rapid increase in knowledge of the genetics and the cell biology of soft tissue tumors. Malignant soft tissue tumors only represent 1% of all malignant tumors in adults. The largest subgroup of soft tissue tumors in adults is the adipocytic tumors. The liposarcoma, which belongs to this subgroup is one of the most common malignant soft tissue tumors in adults. In childhood malignant soft tissue tumors represent 15% of malignant tumors and rhabdomyosarcoma is the most common malignant soft tissue tumor.


Assuntos
Neoplasias de Tecidos Moles/epidemiologia , Neoplasias de Tecidos Moles/patologia , Adulto , Criança , Diagnóstico Diferencial , Tumores do Estroma Gastrointestinal/classificação , Tumores do Estroma Gastrointestinal/epidemiologia , Tumores do Estroma Gastrointestinal/patologia , Histiocitoma Fibroso Maligno/classificação , Histiocitoma Fibroso Maligno/epidemiologia , Histiocitoma Fibroso Maligno/patologia , Humanos , Lipoma/classificação , Lipoma/epidemiologia , Lipoma/patologia , Lipossarcoma/classificação , Lipossarcoma/epidemiologia , Lipossarcoma/patologia , Estadiamento de Neoplasias , Neoplasias de Bainha Neural/classificação , Neoplasias de Bainha Neural/epidemiologia , Neoplasias de Bainha Neural/patologia , Prevalência , Rabdomiossarcoma/classificação , Rabdomiossarcoma/epidemiologia , Rabdomiossarcoma/patologia , Sarcoma/classificação , Sarcoma/epidemiologia , Sarcoma/patologia , Neoplasias de Tecidos Moles/classificação , Terminologia como Assunto , Organização Mundial da Saúde
2.
Exp Mol Pathol ; 74(3): 262-6, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12782013

RESUMO

Overexpression of the cell adhesion protein CD44v6 has been demonstrated in colorectal cancer and other gastrointestinal tumors. While CD44v6 is upregulated in benign colorectal adenomas and well-differentiated colorectal cancer tissues, downregulation frequently occurs during disease progression. The mechanism of downregulation, however, is unknown. Therefore, we evaluated the methylation status of the CD44 promoter as a mechanism for decreased CD44v6 expression in advanced colorectal carcinomas. We demonstrated by methylation-sensitive restriction enzyme digestion that the CpG islands of the CD44 promoter were methylated in 6/21 (28%) of benign colorectal adenomas. Interestingly, in colorectal carcinomas the frequency of promoter methylation was significantly increased (10/19; 53%) compared to 7/21 (33%) in the corresponding normal mucosa. Methylation seems to be associated with a more advanced cancer stage, but the trend did not reach statistical significance. In colorectal carcinomas with CD44 promoter methylation CD44v6 mRNA was detected by reverse transcription-polymerase chain reaction in 3/10 carcinomas, whereas in tumors without CD44 promoter methylation CD44v6 expression was observed in 8/9 (P

Assuntos
Adenocarcinoma/metabolismo , Adenoma/metabolismo , Neoplasias Colorretais/metabolismo , Glicoproteínas/metabolismo , Receptores de Hialuronatos/metabolismo , Regiões Promotoras Genéticas , Adenocarcinoma/genética , Adenocarcinoma/patologia , Adenoma/genética , Adenoma/patologia , Neoplasias Colorretais/genética , Neoplasias Colorretais/patologia , Ilhas de CpG , Primers do DNA/química , Regulação para Baixo , Regulação Neoplásica da Expressão Gênica , Glicoproteínas/genética , Humanos , Receptores de Hialuronatos/genética , Mucosa Intestinal/metabolismo , Metilação , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa
3.
Biochem J ; 342 Pt 3: 691-6, 1999 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-10477281

RESUMO

Transferrin is an essential growth factor for African trypanosomes. Here we show that expression of the trypanosomal transferrin receptor, which bears no structural similarity with mammalian transferrin receptors, is regulated by iron availability. Iron depletion of bloodstream forms of Trypanosoma brucei with the iron chelator deferoxamine resulted in a 3-fold up-regulation of the transferrin receptor and a 3-fold increase of the transferrin uptake rate. The abundance of expression site associated gene product 6 (ESAG6) mRNA, which encodes one of the two subunits of the trypanosome transferrin receptor, is regulated 5-fold by a post-transcriptional mechanism. In mammalian cells the stability of transferrin receptor mRNA is controlled by iron regulatory proteins (IRPs) binding to iron-responsive elements (IREs) in the 3'-untranslated region (UTR). Therefore, the role of a T. brucei cytoplasmic aconitase (TbACO) that is highly related to mammalian IRP-1 was investigated. Iron regulation of the transferrin receptor was found to be unaffected in Deltaaco::NEO/Deltaaco::HYG null mutants generated by targeted disruption of the TbACO gene. Thus, the mechanism of post-transcriptional transferrin receptor regulation in trypanosomes appears to be distinct from the IRE/IRP paradigm. The transferrin uptake rate was also increased when trypanosomes were transferred from medium supplemented with foetal bovine serum to medium supplemented with sera from other vertebrates. Due to varying binding affinities of the trypanosomal transferrin receptor for transferrins of different species, serum change can result in iron starvation. Thus, regulation of transferrin receptor expression may be a fast compensatory mechanism upon transmission of the parasite to a new host species.


Assuntos
Regulação da Expressão Gênica , Ferro/fisiologia , Receptores da Transferrina/genética , Trypanosoma brucei brucei/metabolismo , Aconitato Hidratase/metabolismo , Animais , Northern Blotting , Bovinos , Linhagem Celular , Citoplasma/enzimologia , Proteína 1 Reguladora do Ferro , Proteínas Reguladoras de Ferro , Proteínas Ferro-Enxofre/metabolismo , Processamento de Proteína Pós-Traducional , RNA Mensageiro/metabolismo , Proteínas de Ligação a RNA/metabolismo , Ratos , Transferrina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA